Clostridium novyi
Clostridium novyi | |
---|---|
Scientific classification | |
Domain: | Bacteria |
Phylum: | Bacillota |
Class: | Clostridia |
Order: | Eubacteriales |
Family: | Lachnospiraceae |
Genus: | Clostridium |
Species: | C. novyi
|
Binomial name | |
Clostridium novyi |
Clostridium novyi (oedematiens) a
Growth in culture proceeds through 3 stages: Initial growth wherein no toxin is produced; vigorous growth wherein toxin is produced; and spore formation wherein endospores are formed and toxin production decreases. It is suggested that type C may be type B that forms spores more readily so does not go through the toxin-production stage.
Isolating and identifying C novyi is difficult due to its extreme anaerobic nature. Commercial kits may not be adequate.[2][3]
It is also fastidious and difficult to culture, requiring the presence of
Taxonomy
Clostridium novyi is considered to be made up from three clades, labelled A, B and C, distinguished by the range of
Toxins
This section is missing information about UniProt accession for all toxins.(December 2023) |
The toxins are designated by Greek letters.[7]
C novyi type | Toxins |
---|---|
A | alpha, gamma, delta, epsilon |
B | alpha, beta, zeta |
C | gamma |
The alpha-toxin of Clostridium botulinum types C and D, is similar to the C novyi beta-toxin.[citation needed] The A and B toxins of Clostridium difficile show homology with the alpha-toxin of C novyi as does the lethal toxin of clostridium sordellii.[8]
Alpha-toxin
The alpha-toxin is characterised as lethal and
The type A alpha-toxin is
The duodenum is particularly sensitive to the toxin. Injection into dogs resulted in extreme oedema of the submucosal tissues of the duodenum while leaving the stomach uninjured. Injection into the eye resulted in lesions similar to flame haemorrhages found in diabetic retinopathy.[9]
The toxin is a large 250-k
Beta-toxin
The beta-toxin is characterised as haemolytic, necrotizing lecithinase.[citation needed]
Gamma-toxin
The gamma-toxin is characterised as haemolytic, lecithinase.[citation needed]
Delta-toxin
The delta-toxin is characterised as oxygen labile haemolysin.[citation needed]
Epsilon-toxin
The epsilon-toxin is characterised as lecithino-vitelin[check spelling] and thought to be responsible for the pearly layer found in cultures.
Zeta-toxin
The zeta-toxin is characterised as haemolysin.[citation needed]
Human diseases
The type and severity of the disease caused depends on penetration of the tissues. The epithelium of the alimentary tract, in general, provides an effective barrier to penetration. However, spores may escape from the gut and lodge in any part of the body and result in spontaneous infection should local anaerobic conditions occur.[citation needed]
Tissue penetration
Wound infection by C novyi and many other clostridium species cause gas gangrene[17] Spontaneous infection is mostly associated with predisposing factors of hematologic or colorectal malignancies and with diabetes mellitus,[18] although Gram-negative organisms, including Escherichia coli, may lead to a gas gangrene-like syndrome in diabetic patients. This presents with cellulitis and crepitus, and may be mistaken for gas gangrene.[19] Spontaneous, nontraumatic, or intrinsic infections from a bowel source have been increasingly reported recently.[20]
Clostridium novyi has been implicated in mortality among injecting illegal drug users.[21][22]
Epithelial infections
Symptoms are often non-specific including, colitis[citation needed], oedematous duodenitis[citation needed], and fever with somnolence[citation needed].
Testing is problematical with figures presented by McLauchlin and Brazier [cited above] suggesting a false negative rate of about 40% under ideal conditions. Only positive results may be regarded as reliable. In the absence of a positive test, C. novyi type A may be inferred from characterisation by clinical observation, table 2.
Table 2 | |
---|---|
Observation | Comment |
Oedema | Especially if extreme with rapid onset. In view of the sensitivity of the duodenum to the alpha-toxin, oedematous duodenum is always suspect. |
Anaerobic | Infection occurs at an anaerobic site such as the gut or salivary gland. It may also occur at a site temporarily made anaerobic by occlusion and maintained in this state by oedema. |
Gram positive | If penicillin causes remission of oedema then a Gram positive organism is the causative agent. |
Chronic infection leading to leaky capillaries may also cause retinal haemorrhages and oedema in the lower extremities leading to necrosis and gangrene. Leaky
Animal diseases
Gas gangrene: infectious necrotic hepatitis (black disease)[23]
See also
- Clostridium novyi-NT, an attenuated form being studied for its potential use as a cancer treatment
References
- LPSN.
- PMID 12448683.
- ^ "Identification of Clostridium species". National Standard Methods (PDF). BSOP ID8 Issue 3. Health Protection Agency. July 2008. Archived from the original (PDF) on 2009-11-05. Retrieved 2010-02-26.
- PMID 5721591.
- ^ PMID 11411712.
- PMID 20238541.
- ^ PMID 20238541.
- S2CID 10460632.
- ^ PMID 2744858.
- S2CID 25746652.
- PMID 1612768.
- PMID 11035748.
- S2CID 31949189.
- S2CID 4334048.
- S2CID 38311133.
- S2CID 19531499.
- PMID 2404569.
- PMID 18256217.
- ^ "Necrotising infections". The British Society for Antimicrobial Chemotherapy. Archived from the original on 2003-11-26. Retrieved 2009-08-04.
- S2CID 25810277.
- PMID 14567722. Archived from the originalon 2020-12-12. Retrieved 2020-11-29.
- PMID 12448684.
- OCLC 57355058.
Further reading
- Mengesha, Asferd; Dubois, Ludwig; Paesmans, Kim; Wouters, Brad; Lambin, Philippe; Theys, Jan (2009). "Clostridia in Anti-tumour Therapy". In Brüggemann, Holger; Gottschalk, Gerhard (eds.). Clostridia: Molecular Biology in the Post-genomic Era. Norfolk, England: Caister Academic Press. pp. 199–214. ISBN 978-1-904455-38-7.
- Bettegowda C, Dang LH, Abrams R, et al. (December 2003). "Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria". Proceedings of the National Academy of Sciences of the United States of America. 100 (25): 15083–8. PMID 14657371.
- Groot AJ, Mengesha A, van der Wall E, van Diest PJ, Theys J, Vooijs M (December 2007). "Functional antibodies produced by oncolytic clostridia". Biochemical and Biophysical Research Communications. 364 (4): 985–9. PMID 17971292.
- Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (December 2001). "Combination bacteriolytic therapy for the treatment of experimental tumors". Proceedings of the National Academy of Sciences of the United States of America. 98 (26): 15155–60. PMID 11724950.
- St Jean AT, Zhang M, Forbes NS (October 2008). "Bacterial Therapies: Completing the Cancer Treatment Toolbox". Current Opinion in Biotechnology. 19 (5): 511–7. PMID 18760353.
- Cruz-Morales, Pablo; Orellana, Camila A; Moutafis, George; Moonen, Glenn; Rincon, Gonzalo; Nielsen, Lars K; Marcellin, Esteban (1 July 2019). "Revisiting the Evolution and Taxonomy of Clostridia, a Phylogenomic Update". Genome Biology and Evolution. 11 (7): 2035–2044. PMID 31076745.